Inventor

CAI SUI XIONG

US84 patents

⚠️ This page may combine multiple inventors who share the name “CAI SUI XIONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CAI SUI XIONG

CYTOVIA INC

Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof

Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof

Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereof

Caspase inhibitors and the use thereof

Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

Dipeptide apoptosis inhibitors and the use thereof

Dipeptide caspase inhibitors and the use thereof

Substituted 2-aminobenzamide caspase inhibitors and the use thereof

Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof

Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof

Caspase inhibitors and the use thereof

Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof

Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis

Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof

Substituted alpha-hydroxy acid caspase inhibitors and the use thereof

Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis

Protease inhibitors for coronaviruses and SARS-CoV and the use thereof

Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof

Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof

Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof

Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis

Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis

Substituted N′-(Arylcarbonyl)-benzhydrazides, N′(Arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof

Dipeptide apoptosis inhibitors and the thereof

EURO CELTIQUE SA

Substituted 2-aminoacetamides and the use thereof

Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof

Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof

Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof

Substituted 2-aminoacetamides and the use thereof

Substituted semicarbazides and the use thereof

Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA

WARNER LAMBERT CO

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

Subtype-selective NMDA receptor ligands and the use thereof

4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists

2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists

PURDUE NEUROSCIENCE COMPANY

Substituted 2-aminoacetamides and the use thereof

Substituted 2-aminoacetamides and the use thereof

Substituted 2-aminoacetamides and the use thereof

CAI SUI XIONG

1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

Method of treating brain cancer

LAN NANCY C

Substituted 2-aminoacetamides and the use thereof

MYRIAD PHARMACEUTICALS INC

4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof

COCENSYS INC

Substituted 2,3-benzodiazepin-4-ones and the use thereof

OREGON STATE

Aza and aza (N-oxy) analogs of glycine/NMDA receptor antagonists